Please assess the completion status of the following clinical trial:

Trial Title: Renal Nerve Stimulation and Renal Denervation in Patients With Sympathetic Ventricular Arrhythmias

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~1. The patient is willing and able to comply with the protocol and has provided written informed consent.~2. The patient falls within the target group as stated in 4.1.~3. Patient is an acceptable candidate for RDN treatment~4. Patient is 18-85 years of age~5. Documentation of ventricular arrhythmia (ECG, rhythm strip or ICD interrogation)~Exclusion Criteria:~1. Contraindication to anticoagulation therapy or heparin.~2. Previous selective cardiac sympathetic denervation or previous RDN procedure.~3. Acute coronary syndrome, cardiac surgery, PCI or stroke within 3 months prior to enrolment.~4. Untreated hypothyroidism or hyperthyroidism.~5. More than grade 1/3 valvular regurgitation and/or significant valve stenosis (moderate or severe).~6. Severe LV dysfunction (LVEF \<20% and/or grade 3/4 diastolic dysfunction).~7. Enrolment in another investigational drug or device study.~8. Woman currently pregnant or breastfeeding or not using reliable contraceptive measures during fertile age.~9. Mental or physical inability to participate in the study.~10. Planned cardiovascular intervention.~11. Life expectancy ≤ 12 months.~12. Renal artery stenosis \>50% of the arterial lumen, or renal artery lumen ≤3 mm.~13. Complex renal artery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- CPVT (Type: OTHER): catecholaminergic polymorphic ventricular tachycardia (CPVT) patients
- long QT syndrome (Type: OTHER): long QT syndrome patients
- ARVC (Type: OTHER): arrhythmogenic right ventricular cardiomyopathy (ARVC) patients
- HCM (Type: OTHER): hypertrophic cardiomyopathy (HCM) patients
- DCM (Type: OTHER): dilated non-ischemic cardiomyopathy (DCM) patients
- ICM (Type: OTHER): ischemic cardiomyopathy (ICM) patients

Based on this trial design, predict the completion outcome and termination type (if applicable).